VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the initiation of cell line development for its lead BiTAC ® T-cell engager ...

Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 770,000 shares ...

US envoys Jared Kushner and Steve Witkoff meet Qatari mediators in Doha as Washington and Tehran send delegations amid ...

ADF GROUP INC. ("ADF" or the "Corporation") (Stock symbol:TSX: DRX), a North American leader in the fabrication of steel superstructures announced today its intention to enter into an agreement with ...

Circle, the issuer of the USDC stablecoin, has published new insights highlighting how programmable money is reshaping enterprise payments. The company’s ...

Jul. 2—As we've stated previously, the cost of a four-year college degree presents a financial non-starter for many high-school graduates. But it also presents an opportunity to explore other ...

July 2, 2026) - OS Therapies, Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in gene-edited, Listeria-based cancer immunotherapies, today announced that it has ...

Alberta Premier Danielle Smith and Prime Minister Mark Carney have announced a route and a tentative partnership for a new ...

Despite severe fuel shortages across Russia, President Vladimir Putin appears unbothered by Ukraine’s increasing attacks on ...

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...

Company secures $10 million line of credit supported by OS Therapies UK tax creditsNew York, New York and Rockville, Maryland--(Newsfile Corp. - July 2, 2026) - OS Therapies, Inc. (NYSE American: OSTX ...